نتائج البحث - "Matthias Zeis"

1

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

المؤلفون: Stephan Stilgenbauer, Sebastian Böttcher, Hartmut Döhner, Ute Hegenbart, Norbert Schmitz, Lutz Uharek, Michael Stadler, Peter Dreger, Isabelle Krämer, Anthony D. Ho, Sascha Dietrich, Christof Scheid, Matthias Zeis, Michael Hallek, Jörg Thomas Bittenbring, Michael Kneba

المصدر: Blood. 130:1477-1480

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8fbadad1b8b01f25b15055a6900d847aTest
https://doi.org/10.1182/blood-2017-04-775841Test

2

Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies

المؤلفون: Matthias Zeis, Norbert Schmitz, Matthias Marget, Andreas Wagner, Dieter Kabelitz, James W. Rohrer, Sandra Siegel, Adel L. Barsoum, Joseph H. Coggin

المصدر: Blood. 102:4416-4423

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd2bb294213e0fe0d1d1a5fe0e8b23cTest
https://doi.org/10.1182/blood-2003-01-0198Test

3

Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells

المؤلفون: L Uharek, Matthias Zeis, Christof Lehmann

المصدر: British Journal of Haematology. 114:660-665

مصطلحات موضوعية: Lymphokine-activated killer cell, biology, Degranulation, chemical and pharmacologic phenomena, Hematology, Natural killer cell, Cell biology, Interleukin 21, medicine.anatomical_structure, Perforin, NK-92, Granzyme, medicine, biology.protein, Interleukin 12

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ef346183038aef0e720666a78a758208Test
https://doi.org/10.1046/j.1365-2141.2001.02995.xTest

4

Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

المؤلفون: Matthias Zeis, Donald Bunjes, Hartmut Döhner, Matthias Ritgen, Peter Dreger, Michael Kneba, Michael Stadler, Ute Hegenbart, Michael Hallek, Stephan Stilgenbauer, Isabelle Krämer, Sebastian Böttcher, Sascha Dietrich, Joerg Thomas Bittenbring, Norbert Schmitz

المصدر: Blood. 128:682-682

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::65ee82d7df78e00d0a2ac308d12ee579Test
https://doi.org/10.1182/blood.v128.22.682.682Test

5

Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells

المؤلفون: Norbert Schmitz, L. Uharek, Matthias Zeis, Christof Lehmann

المصدر: Blood. 96:594-600

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5028d80a24807867f1b6e4b1c603044aTest
https://doi.org/10.1182/blood.v96.2.594.014k36_594_600Test

6

Allogeneic Peripheral Blood Progenitor Cell Transplantation in a Murine Model: Evidence for an Improved Graft-Versus-Leukemia Effect

المؤلفون: Norbert Schmitz, Jörg Steinmann, B. Glass, Peter Dreger, Helmut Löffler, L. Uharek, Matthias Zeis

المصدر: Blood. 90:1694-1700

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30181a1ef0ee2fc50ca98405dae410bfTest
https://doi.org/10.1182/blood.v90.4.1694Test

7

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial

المصدر: Blood. 121(16)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Chronic lymphocytic leukemia, medicine.medical_treatment, Immunology, Population, Hematopoietic stem cell transplantation, Biochemistry, Disease-Free Survival, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Transplantation, Homologous, Receptor, Notch1, education, Aged, education.field_of_study, business.industry, Hematopoietic Stem Cell Transplantation, Cancer, Cell Biology, Hematology, Middle Aged, Ribonucleoprotein, U2 Small Nuclear, medicine.disease, Phosphoproteins, Minimal residual disease, Leukemia, Lymphocytic, Chronic, B-Cell, Fludarabine, Transplantation, Leukemia, Treatment Outcome, Mutation, Female, RNA Splicing Factors, Tumor Suppressor Protein p53, business, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dbf3b65018542c649671160794f136dTest
https://pubmed.ncbi.nlm.nih.gov/23435461Test

8

Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma

المؤلفون: Bärbel Schurich, Uta Bertsch, Elias K. Mai, Mathias Haenel, Katja Weisel, Maximilian Merz, Igor Wolfgang Blau, Jan Duerig, Christian Gerecke, Markus Munder, Peter Brossart, Thomas Hielscher, Christina Kunz, Dirk Hose, Matthias Zeis, Hans-Juergen Salwender, Hartmut Goldschmidt, Christof Scheid, Hans Walter Lindemann

المصدر: Blood. 126:4233-4233

مصطلحات موضوعية: medicine.medical_specialty, Univariate analysis, business.industry, Bortezomib, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Surgery, Clinical trial, Peripheral neuropathy, Maintenance therapy, Interquartile range, Internal medicine, medicine, business, Multiple myeloma, medicine.drug, Lenalidomide

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1fb05c868e82bde5f3e52fbf0653425aTest
https://doi.org/10.1182/blood.v126.23.4233.4233Test

9

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

المصدر: Blood. 116(14)

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Neoplasm, Residual, Transplantation Conditioning, Cyclophosphamide, Adolescent, Chronic lymphocytic leukemia, Immunology, Medizin, Graft vs Host Disease, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Germany, medicine, Humans, Transplantation, Homologous, Prospective Studies, Risk factor, Aged, Hematology, Genome, business.industry, Cell Biology, Middle Aged, medicine.disease, Prognosis, Minimal residual disease, Leukemia, Lymphocytic, Chronic, B-Cell, 3. Good health, Fludarabine, Surgery, Transplantation, Treatment Outcome, 030220 oncology & carcinogenesis, Lymphocyte Transfusion, Alemtuzumab, business, 030215 immunology, medicine.drug, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499229935ad37b67b315afd84d104546Test
https://pubmed.ncbi.nlm.nih.gov/21218528Test

10

Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma – Subgroup Analysis from the GMMG-MM5 Trial

المؤلفون: Hans Salwender, Christina Kunz, Hans Walter Lindemann, Jan Duerig, Maximilian Merz, Thomas Hielscher, Markus Munder, Elias K. Mai, Baerbel Schurich, Christof Scheid, Hartmut Goldschmidt, Katja Weisel, Matthias Zeis, Uta Bertsch, Dirk Hose, Ingo G.H. Schmidt-Wolf, Igor Wolfgang Blau, Christian Gerecke, Mathias Hänel

المصدر: Blood. 124:3475-3475

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e624fc773bf3556779921bff106e28b1Test
https://doi.org/10.1182/blood.v124.21.3475.3475Test

تنقيح النتائج